DNA sequences can be engineered to form nanocages or other structures capable of carrying therapeutic agents. These DNA-based delivery systems can be designed to target specific cells or tissues, releasing their cargo in response to certain stimuli such as pH, temperature, or the presence of specific molecules. This targeted approach can enhance the efficacy of drugs and reduce side effects.
